shop now
clinical laboratory standards institute logo

 

News & Events

CLSI Releases Newborn Screening Document to Aid in the Detection of Severe Combined Immunodeficiency

Wayne, Pennsylvania, USA—May 2013—Clinical and Laboratory Standards Institute (CLSI) has released NBS06-A—Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline. Severe combined immunodeficiency (SCID) is a lethal disorder not evident at birth. This document addresses its detection by population-based newborn screening (NBS), which uses dried blood spot (DBS) specimens to measure T-cell receptor excision circles (TREC). TREC may be used to reveal the presence of SCID, and this presymptomatic detection is required for effective treatment.

Read More.

 

View Our Latest eNews

Access this month’s newsletter featuring the updates on all CLSI program areas.

Read Now

Sign Up For eNews Now!

Login


8 × = forty


Register | Lost your password?